Icon Wealth Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$223K Sell
3,895
-9,020
-70% -$722K 0.01% 366
2025
Q4
$1.23M Sell
12,915
-5,165
-29% -$506K 0.08% 157
2025
Q3
$1.77M Buy
18,080
+16,115
+820% +$1.67M 0.12% 126
2025
Q2
$211K Buy
1,965
+490
+33% +$49.6K 0.02% 361
2025
Q1
$149K Buy
1,475
+282
+24% +$28.4K 0.01% 405
2024
Q4
$107K Hold
1,193
0.01% 491
2024
Q3
$100K Buy
+1,193
New +$94K 0.01% 479
2022
Q4
Sell
-3,657
Closed -$142K 341
2022
Q3
$142K Buy
+3,657
New +$147K 0.02% 344

Other funds holding BSX

Icon Wealth Advisors's BSX Position: Q1 2026 in Review

Icon Wealth Advisors reduced its Boston Scientific (BSX) stake by 70% in Q1 2026, selling an estimated $722K and leaving 3,895 shares worth $223K. The position accounts for 0.01% of the portfolio, ranked #366.

Icon Wealth Advisors first reported a position in BSX in Q3 2022 and has held it in 8 quarters since. The position peaked at $1.77M in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Icon Wealth Advisors held 3,895 shares of Boston Scientific worth $223K as of Q1 2026.
  • Icon Wealth Advisors sold 9,020 Boston Scientific shares in Q1 2026, an estimated $722K.
  • Boston Scientific made up 0.01% of Icon Wealth Advisors's portfolio in Q1 2026, its #366 holding.
  • Icon Wealth Advisors first reported a position in Boston Scientific in Q3 2022 and has held it in 8 quarters since.
  • Icon Wealth Advisors's Boston Scientific position peaked at $1.77M in Q3 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Icon Wealth Advisors's 13F filing for Q1 2026, filed 12 May 2026.